OpenClinica, LLC, announces the availability of the latest version of its popular open source clinical trials software. The OpenClinica v3.1.3 release contains over 100 fixes and enhancements, including:
These, and many other, advancements are the result of efforts by OpenClinica, LLC and members of the OpenClinica community. “OpenClinica community contributors have helped fuel a lot of the progress reflected in this release,” said Cal Collins, OpenClinica’s CEO. “This release is evidence that a strong open source community can drive the software to a higher quality standard.”
OpenClinica 3.1.3 Community Edition is freely available for download on the OpenClinica community website.
The company also announces that version 3.1.3 of its commercially backed OpenClinica Enterprise Edition is also now available. OpenClinica Enterprise is provided as fully validated, enhanced, and supported implementation of the open source technology, ideal for mission critical environments. This latest rendition of the OpenClinica Enterprise Edition also leverages Akamai’s global content delivery network (CDN), further accelerating the application’s performance.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.